Company news

Hlb Co., Ltd. (KRX:028300) news

Hlb Co., Ltd. news releases on 6ix. Latest, Jan 30, 2026: Elevar Therapeutics' NDA Resubmission For Rivoceranib With Camrelizumab Accepted By FDA

View Hlb Co., Ltd. →